Thus, promoter hypermethylation does not seem to be a prevalent mechanism underlying microRNA downregulation in this cancer model, and other causes, whether genetic [29], epigenetic [30] or microenvironment-related (e.g., abnormal AR signaling [31]), are likely to be more frequent. The gene discussed is AR; the disease is cancer.